Skip to main content
. 2010 Feb 10;28(6):1635–1641. doi: 10.1016/j.vaccine.2009.11.004

Table 3.

Principal components analysis.

Component Eigenvalue Difference Proportion Cumulative
Component 1 7.28 4.3 0.49 0.49
Component 2 2.98 1.64 0.2 0.68
Component 3 1.33 0.33 0.09 0.77
Component 4 1.01 0.18 0.07 0.84
Component 5 0.83 0.35 0.06 0.9
Component 6 0.48 0.15 0.03 0.93
Component 7 0.33 0.09 0.02 0.95
Component 8 0.24 0.08 0.02 0.97
Component 9 0.16 0.05 0.01 0.98
Component 10 0.11 0.02 0.01 0.98
Component 11 0.08 0.02 0.01 0.99
Component 12 0.07 0.03 0 0.99
Component 13 0.04 0.01 0 1
Component 14 0.03 0.03 0 1
Component 15 0.01 0 1
Variable Component 1 Component 2
Log IFNγ 0.33 0.11
Log IL-2 0.26 −0.1
Log IL-4 0.08 0.45
Log IL-5 0.25 0.3
Log IL-6 0.3 −0.09
Log IL-8 0.31 −0.01
Log IL-10 −0.11 0.5
Log IL-13 0.25 0.13
Log IL-17 0.01 0.39
Log IL-1α 0.31 −0.15
Log G-CSF 0.26 −0.16
Log GM-CSF 0.34 0.03
Log TNFα 0.34 0.06
Log MIP-1α 0.3 −0.17
Log IP-10 0.1 0.43

Principal components analysis of 15 cytokines from supernatants stimulated with M.tb PPD from infants 3 months post-BCG vaccination. Shaded boxes show important cytokines in the component.